{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:01:30Z","timestamp":1774339290557,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.diagmicrobio.2018.09.004","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T02:39:45Z","timestamp":1536892785000},"page":"131-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Daptomycin for the treatment of Staphylococcus aureus infections complicated by septic pulmonary emboli"],"prefix":"10.1016","volume":"93","author":[{"given":"Ryan L.","family":"Crass","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey L.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0005","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and Management of Complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0010","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cid\/civ444","article-title":"Comparison of the effectiveness and safety of linezolid and Daptomycin in vancomycin-resistant Enterococcal bloodstream infection: a National Cohort Study of veterans affairs patients","volume":"61","author":"Britt","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0015","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1128\/AAC.02371-13","article-title":"Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy","volume":"58","author":"Casapao","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1378\/chest.128.1.162","article-title":"Septic pulmonary embolism: presenting features and clinical course of 14 patients","volume":"128","author":"Cook","year":"2005","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0025","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.hrtlng.2005.05.006","article-title":"Daptomycin cure after cefazolin treatment failure of methicillin-sensitive Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis from a peripherally inserted central catheter (PICC) line","volume":"34","author":"Cunha","year":"2005","journal-title":"Heart Lung"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0030","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jac\/46.5.775","article-title":"Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid emergency-use study group","volume":"46","author":"Drew","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jac\/dkl219","article-title":"Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence","volume":"58","author":"Falagas","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0040","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/mdr.2010.0001","article-title":"Daptomycin and rifampin for the treatment of methicillin-resistant Staphylococcus aureus septic pulmonary emboli in the absence of endocarditis","volume":"16","author":"Gomez","year":"2010","journal-title":"Microb Drug Resist"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40121-015-0075-9","article-title":"Daptomycin for the treatment of infective endocarditis: results from European Cubicin((R)) outcomes registry and experience (EU-CORE)","volume":"4","author":"Guleri","year":"2015","journal-title":"Infect Dis Ther"},{"issue":"22","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0055","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.2169\/internalmedicine.52.0023","article-title":"Ineffectiveness of daptomycin in the treatment of septic pulmonary emboli and persistent bacteremia caused by methicillin-resistant Staphylococcus aureus","volume":"52","author":"Hagiya","year":"2013","journal-title":"Intern Med"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0060","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1128\/AAC.02331-12","article-title":"In vivo efficacy of daptomycin against methicillin-resistant Staphylococcus aureus in a mouse model of hematogenous pulmonary infection","volume":"57","author":"Harada","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0065","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1128\/AAC.01050-06","article-title":"Determination of antibiotic efficacy against bacillus anthracis in a mouse aerosol challenge model","volume":"51","author":"Heine","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0070","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/AAC.00210-10","article-title":"Efficacy of Daptomycin against bacillus anthracis in a murine model of anthrax spore inhalation","volume":"54","author":"Heine","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0075","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/jac\/dks006","article-title":"Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy","volume":"67","author":"Ho","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0080","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.eimc.2009.07.015","article-title":"Daptomycin compared to standard therapy for the treatment of native valve endocarditis","volume":"28","author":"Kanafani","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/jac\/21.1.33","article-title":"Comparison of the investigational drug, LY146032, with vancomycin in experimental pneumonia due to methicillin-resistant Staphylococcus aureus","volume":"21","author":"Kephart","year":"1988","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s10156-012-0449-9","article-title":"The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients","volume":"19","author":"Lin","year":"2013","journal-title":"J Infect Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0095","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ijantimicag.2008.07.004","article-title":"Development of multiple lung abscesses during daptomycin treatment for right-sided endocarditis caused by meticillin-resistant Staphylococcus aureus","volume":"32","author":"Liu","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0100","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1128\/AAC.00857-10","article-title":"Successful treatment of vancomycin-intermediate Staphylococcus aureus pacemaker lead infective endocarditis with telavancin","volume":"54","author":"Marcos","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0105","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-117-5-390","article-title":"Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection","volume":"117","author":"Markowitz","year":"1992","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1469-0691.2006.01585.x","article-title":"Linezolid therapy for infective endocarditis","volume":"13","author":"Munoz","year":"2007","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","article-title":"Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study","volume":"169","author":"Murdoch","year":"2009","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0120","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/jac\/dkq113","article-title":"Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin","volume":"65","author":"Nace","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0125","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1378\/chest.108.2.460","article-title":"Pulmonary complications associated with illicit drug use. An update","volume":"108","author":"O'Donnell","year":"1995","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0130","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1086\/533441","article-title":"Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia","volume":"46","author":"Pertel","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0135","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/jac\/dkn372","article-title":"Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates","volume":"62","author":"Rehm","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0140","first-page":"137","article-title":"Endovascular infections arising from right-sided heart structures","volume":"10","author":"Remetz","year":"1992","journal-title":"Cardiol Clin"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/00365548.2014.995696","article-title":"Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis","volume":"47","author":"Ruggero","year":"2015","journal-title":"Infect Dis (Lond)"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0150","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00134-002-1358-7","article-title":"Clinical experience with quinupristin-dalfopristin as rescue treatment of critically ill patients infected with methicillin-resistant staphylococci","volume":"28","author":"Sander","year":"2002","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0155","first-page":"97","article-title":"Clinical outcome with oral linezolid and rifampin following recurrent methicillin-resistant Staphylococcus aureus bacteremia despite prolonged vancomycin treatment","volume":"15","author":"Schwalm","year":"2004","journal-title":"Can J Infect Dis"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0160","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1086\/430352","article-title":"Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact","volume":"191","author":"Silverman","year":"2005","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0165","doi-asserted-by":"crossref","DOI":"10.1007\/s11908-014-0429-6","article-title":"High-dose daptomycin therapy for staphylococcal endocarditis and when to apply it","volume":"16","author":"Smith","year":"2014","journal-title":"Curr Infect Dis Rep"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0170","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1159\/000238615","article-title":"LY146032 in a hamster model of Staphylococcus aureus pneumonia--effect on in vivo clearance and mortality and in vitro opsonophagocytic killing","volume":"34","author":"Verghese","year":"1988","journal-title":"Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2018.09.004_bb0175","series-title":"Contemporary Challenges in Endocarditis","article-title":"Septic Embolism: A Potentially Devastating Complication of Infective Endocarditis","author":"Wojda","year":"2016"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0180","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jac\/dkw450","article-title":"Linezolid: a promising option in the treatment of gram-positives","volume":"72","author":"Zahedi Bialvaei","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2018.09.004_bb0185","article-title":"Daptomycin failure for treatment of pulmonary septic emboli in native tricuspid and mitral valve methicillin-resistant Staphylococcus aureus endocarditis","volume":"2013","author":"Zainah","year":"2013","journal-title":"Case Rep Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.09.004_bb0190","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02015-16","article-title":"Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections","volume":"61","author":"Zasowski","year":"2017","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318303468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318303468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:52:04Z","timestamp":1760003524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889318303468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0732889318303468"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.09.004","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daptomycin for the treatment of Staphylococcus aureus infections complicated by septic pulmonary emboli","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}